Electromed, Inc. (ELMD) Stock Price & Analysis
Electromed, Inc. (ELMD) rose 0.60% to USD 38.41 as of July 25, 2026 at 08:25 UTC, according to Nexqual real-time market data.
ELMD last closed at USD 38.18; the session ranged USD 37.77–39.16 on volume of 65,334 shares. Market capitalization is $318.04M, with a 52-week range of USD 17.73–47.4 (ASE). Source: Nexqual, July 25, 2026 at 08:25 UTC.
Key Statistics (as of July 25, 2026 at 08:25 UTC)
| Price | USD 38.41 |
|---|---|
| Change | ▲ 0.60% (up) |
| Previous Close | USD 38.18 |
| Open | USD 38.32 |
| Day Range | USD 37.77 – 39.16 |
| 52-Week Range | USD 17.73 – 47.4 |
| Volume | 65,334 shares |
| Market Cap | $318.04M |
| Exchange | ASE |
Technical Analysis (ELMD)
Nexqual's technical model rates ELMD "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 08:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.94 (neutral) |
| vs SMA50 | Below (USD 39.69) |
| MACD | 0.09 (positive) |
Analyst Ratings (ELMD)
Wall Street analysts rate ELMD "None" based on 3 analysts, with a mean price target of USD 40.33 (range USD 36–45), per Nexqual as of July 25, 2026 at 08:25 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 40.33 |
| High Target | USD 45 |
| Low Target | USD 36 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ELMD)
| Next Earnings Date | 2026-08-25 |
|---|---|
| Revenue Estimate | $19.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD 0.32 vs est 0.26 ▲ beat |
| 2025-09-30 | USD 0.25 vs est 0.21 ▲ beat |
| 2025-06-30 | USD 0.25 vs est 0.22 ▲ beat |
Source: Nexqual, July 25, 2026 at 08:25 UTC.
Financials & Fundamentals (ELMD)
| Total Revenue | $71.75M |
|---|---|
| Revenue Growth (YoY) | +18.40% |
| Gross Margin | +78.44% |
| Operating Margin | +20.28% |
| Profit Margin | +14.08% |
| ROE | +21.70% |
| Debt / Equity | 0.17 |
| Current Ratio | 4.91 |
| Total Cash | $16.98M |
| Total Debt | $81,000 |
| Free Cash Flow | $8.32M |
Source: Nexqual, July 25, 2026 at 08:25 UTC.
Financial Health Score (ELMD)
Nexqual rates Electromed, Inc.'s overall financial health "Strong" across five dimensions, as of July 25, 2026 at 08:25 UTC.
| Growth | Strong — Revenue +17% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 78%, operating 20% |
| Balance Sheet | Strong — $17M cash, no debt |
| Cash Flow | Solid — FCF $8M, 13% margin |
| Efficiency | Strong — ROE 22%, ROA 14.9% |
Ownership (ELMD)
| Insider Ownership | +17.18% |
|---|---|
| Institutional Ownership | +58.46% |
| Shares Outstanding | 8.28M |
| Float | 6.85M |
| Short % of Float | +2.52% |
Source: Nexqual, July 25, 2026 at 08:25 UTC.
Leadership (ELMD)
Electromed, Inc. is led by James L. Cunniff (age 59), President, CEO & Director, per Nexqual as of July 25, 2026 at 08:25 UTC.
| President, CEO & Director | James L. Cunniff (age 59) |
|---|---|
| CFO, Treasurer & Secretary | Bradley M. Nagel (age 43) |
Major Backers & Investors (ELMD)
Notable institutional backers of Electromed, Inc. include J.e. Simmons & Co., P.c., Punch & Associates Investment Management, Inc., Acadian Asset Management. LLC, according to Nexqual as of July 25, 2026 at 08:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| J.e. Simmons & Co., P.c. | 5.84% |
| Punch & Associates Investment Management, Inc. | 2.71% |
| Acadian Asset Management. LLC | 2.69% |
| Two Sigma Investments, LP | 2.46% |
| Hunter Associates Investment Management LLC | 1.88% |
| Gamco Investors, Inc ET AL | 1.71% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.46% |
| BlackRock | 8.13% |
| Geode Capital | 2.44% |
| Dimensional Fund Advisors | 2.15% |
Source: Nexqual, July 25, 2026 at 08:25 UTC.
From Electromed, Inc.'s Latest SEC 10-K Filing (filed 2025-08-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
- It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
- It markets its products to physicians, health care providers, and directly to patients.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INFU | InfuSystems Holdings, Inc. | USD 9.12 | ▲ 2.47% |
| PDEX | Pro-Dex, Inc. | USD 54.93 | ▲ 2.81% |
| DLHC | DLH Holdings Corp. | USD 5.09 | ▼ 0.78% |
| IRMD | iRadimed Corporation | USD 94.49 | ▲ 0.44% |
| KRMD | KORU Medical Systems, Inc. | USD 3.83 | ▼ 0.78% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:25 UTC. This page is informational and not investment advice.